MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235)
Hong Kong · Delayed Price · Currency is HKD 6.88
-0.27 (-3.78%)
Aug 21, 2026, 3:59 PM HKT
HKG:2235 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 820.23 | 652.02 | 340.35 | 248.35 | 169.89 | 151.4 |
Other Revenue | 8.76 | 8.76 | 5.26 | 4.88 | 3.72 | - |
| 828.99 | 660.79 | 345.62 | 253.23 | 173.61 | 151.4 | |
Revenue Growth | 88.09% | 91.19% | 36.48% | 45.86% | 14.67% | 101.13% |
Cost of Revenue | 368.72 | 312.48 | 166.54 | 136.08 | 93.91 | 80.52 |
Gross Profit | 460.27 | 348.31 | 179.08 | 117.14 | 79.69 | 70.88 |
Selling, General & Admin | 308.88 | 271.34 | 249.28 | 250.62 | 158.23 | 93.74 |
Research & Development | 85.74 | 76.34 | 76.56 | 70.1 | 61.09 | 36.08 |
Other Operating Expenses | -7.7 | -0.01 | -12.68 | -9.28 | -21.99 | - |
Operating Expenses | 384.41 | 349.2 | 314.6 | 312.43 | 200.04 | 131.05 |
Operating Income | 75.86 | -0.89 | -135.52 | -195.29 | -120.34 | -60.17 |
Interest Expense | -0.89 | -0.13 | -0.68 | -0.05 | -0.15 | -0.02 |
Interest & Investment Income | 51.16 | 53.9 | 64.25 | 68.24 | 55.72 | 24.49 |
Currency Exchange Gain (Loss) | -18.14 | -18.14 | 9.7 | 7.11 | 29.95 | -16.48 |
Other Non Operating Income (Expenses) | -32.21 | -0.33 | -0.16 | -4.68 | -0.22 | 3.97 |
EBT Excluding Unusual Items | 75.78 | 34.41 | -62.41 | -124.67 | -35.03 | -48.2 |
Gain (Loss) on Sale of Investments | -0.03 | -0.03 | 0.09 | -0.02 | - | - |
Gain (Loss) on Sale of Assets | 0.01 | 0.01 | - | - | -0.01 | 0.05 |
Asset Writedown | 1.26 | -0 | -0.83 | -0.16 | -0 | - |
Other Unusual Items | 6.02 | 6.02 | - | 0 | - | - |
Pretax Income | 83.04 | 40.4 | -63.15 | -124.85 | -35.04 | -48.15 |
Income Tax Expense | 0.32 | 0.25 | -0.03 | 0.16 | 0 | - |
Earnings From Continuing Operations | 82.72 | 40.15 | -63.12 | -125.02 | -35.04 | -48.15 |
Net Income | 82.72 | 40.15 | -63.12 | -125.02 | -35.04 | -48.15 |
Net Income to Common | 82.72 | 40.15 | -63.12 | -125.02 | -35.04 | -48.15 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 385 | 413 | 421 | 431 | 438 | 373 |
Shares Outstanding (Diluted) | 386 | 414 | 421 | 431 | 438 | 373 |
Shares Change | -7.64% | -1.63% | -2.39% | -1.59% | 17.39% | 21.79% |
EPS (Basic) | 0.21 | 0.10 | -0.15 | -0.29 | -0.08 | -0.13 |
EPS (Diluted) | 0.21 | 0.10 | -0.15 | -0.29 | -0.08 | -0.13 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | -6.31 | -203.88 | -153 | -148.79 | -61.82 |
Free Cash Flow Per Share | - | -0.01 | -0.48 | -0.35 | -0.34 | -0.17 |
Gross Margin | 55.52% | 52.71% | 51.81% | 46.26% | 45.91% | 46.82% |
Operating Margin | 9.15% | -0.14% | -39.21% | -77.12% | -69.32% | -39.74% |
Profit Margin | 9.98% | 6.08% | -18.26% | -49.37% | -20.18% | -31.80% |
Free Cash Flow Margin | - | -0.95% | -58.99% | -60.42% | -85.71% | -40.83% |
EBITDA | 88.25 | 11.4 | -123.42 | -184.12 | -110.19 | -52.28 |
EBITDA Margin | 10.64% | 1.73% | -35.71% | -72.71% | -63.47% | -34.53% |
D&A For EBITDA | 12.39 | 12.29 | 12.1 | 11.17 | 10.15 | 7.88 |
EBIT | 75.86 | -0.89 | -135.52 | -195.29 | -120.34 | -60.17 |
EBIT Margin | 9.15% | -0.14% | -39.21% | -77.12% | -69.32% | -39.74% |
Effective Tax Rate | 0.39% | 0.62% | - | - | - | - |
Revenue as Reported | 660.79 | 660.79 | 345.62 | 253.23 | 173.61 | - |